Back to Top Skip to main content Skip to sub-navigation

Military Health System participating in COVID-19 vaccine trial

Woman measuring out a vaccine into a needle Five military medical treatment facilities are participating in a Phase 3 clinical trial testing a COVID-19 vaccine in development with AstraZeneca. (Photo by Air Force Staff Sgt. Joshua Garcia.)

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Vaccine Trials

Five military medical treatment facilities in the National Capital Region, Texas, and California are participating in a phase 3 clinical trial testing the AstraZeneca COVID-19 vaccine in development under Operation Warp Speed.  The DoD sites are actively enrolling study participants, with a goal to recruit up to 1,000 volunteers in each of the three market areas towards the total AstraZeneca clinical trial enrollment of 30,000 people.

Operation Warp Speed, a multiagency U.S. Government effort led by the Department of Health and Human Services and the Department of Defense, is working with the private sector with the aims to deliver safe and effective COVID-19 vaccine doses to the American public beginning January 2021.

OWS is funding clinical trials evaluating several vaccine candidates which were selected based on promising data on safety, immune response, and protection in animal studies and safety and immune response data in early-stage trials in humans. Each of the trials is designed to collect data on how well a vaccine candidate protects against COVID-19 and on the safety of the vaccine candidate in a larger population, including people most at risk.  

“The Department of Defense continues to play a key role in the development of a potential COVID-19 vaccine,” said Thomas McCaffery, assistant secretary of Defense for Health Affairs. “Now that vaccines have passed the first phases of testing for safety, dosing, and response, we have moved into the next phase where volunteers are needed to join large clinical studies. We are excited to have several sites supporting these next steps in the vaccine development process.”

Large phase 3 clinical trials are a necessary part of the rigorous scientific process to test the efficacy and safety of a vaccine in a real-world setting with a large population sample, said Air Force Col (Dr.) Jessica Cowden, chief medical officer of the DoD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnology Vaccine Acceleration Project.

“Phase 3 studies are designed to evaluate if the vaccine can prevent disease in the populations of people that the vaccine is being developed to protect,” said Cowden. “Phase 3 studies are large and usually involve some people who are at risk for infection and disease.”

The National Institute of Allergy and Infectious Diseases at the National Institutes of Health established a network of infectious disease experts and research partners, termed the Coronavirus Prevention Network, or CoVPN, to rapidly and thoroughly evaluate U.S. government-sponsored COVID-19 vaccines. The CoVPN website (https://www.coronaviruspreventionnetwork.org/) provides general information about products being developed to prevent COVID-19 and about clinical trials.

According to the CoVPN, interested volunteers must be adults aged 18 and older to be screened for these initial trials. The CoVPN recognizes the importance of including volunteers who are more likely to get COVID-19, such as those over the age of 65 or with underlying medical conditions; as well as people who work in an essential job, live in a densely populated area, or represent a racial and ethnic group greatly impacted by the epidemic.

Representation by such groups matters in Phase 3 trials because vaccines need to be tested in populations who are at most risk of being exposed to the disease and getting sick in the real world, explained Cowden. “At-risk populations shouldn’t bear a disproportionate burden of research, but they need to be represented,” she said

The selected DoD sites are currently enrolling volunteers for the AstraZeneca clinical trial, according to Cowden. The trial is a randomized control, double-blind study, meaning volunteers will either receive the study vaccine or saline. “The study team and the participant will be blinded so that they won’t know which the participant received until the end of the study,” Cowden said. AstraZeneca’s vaccine candidate is in late-stage clinical trials ongoing in the U.K., Brazil and South Africa.

“Participating in a vaccine clinical trial is voluntary but is also critically vital to ensure that the overall effort is ultimately successful,” said Dr. Sean Biggerstaff, acting deputy director, DHA Research and Development Directorate. “Volunteers should also know safety remains an overriding priority for anyone participating in clinical trials.”

Military health beneficiaries who wish to volunteer for the AstraZeneca COVID-19 vaccine at a nearby military medical treatment facility (or at a civilian site close to home) can contact the local study team directly to request more information or can register on the CoVPN website and consent to be contacted by a research team. If registering on the CoVPN site, interested volunteers should enter the appropriate code in parenthesis from the list below, or enter their ZIP code to join the registry. Site contact information is included here:

At this point, the DoD is only participating in the AstraZeneca study. Additional DoD sites are being prepared for participation in other clinical trials of vaccines and monoclonal antibodies to prevent COVID-19, said Cowden.

“Having a safe and effective COVID-19 vaccine is what we need to protect people and get life back to normal, but in order to get to that point, we have to do these clinical trials,” explained Cowden. “These big Phase 3 clinical trials with a lot of people participating are critical so we can get the information we need to determine if a vaccine candidate is safe and can prevent COVID-19.”

You also may be interested in...

Presentation Companion

Publication
5/7/2021

Leaders and public affairs officers may reference this document. It can be shared with commands to support briefings, or distributed independently to share facts about COVID-19 vaccines.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Nurse and Tech Week: Air Force airmen are battle-tested and ready

Article
5/6/2021
12 COVID-19 patients aboard a C-17 Globemaster III aircraft

For the past year, Air Force nurses and medical technicians have found themselves on the front lines in the battle against the COVID-19 disease.

Recommended Content:

COVID-19 Vaccine Toolkit | National Nurses Week | Technology | Nurses Week | May Toolkit | Coronavirus

EACH celebrates National Nurses Week with a reflection on the pandemic

Article
5/6/2021
Military health personnel inputting information into a computer

Evans Army Community Hospital celebrates National Nurses Week 2021.

Recommended Content:

National Nurses Week | Nurses Week | Coronavirus | COVID-19 Vaccine Toolkit

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

Got Your 6 - May 6, 2021

Video
5/6/2021
Video screen image for the May 6, 2021 Got Your Six video

"Got Your 6" is TRICARE's COVID-19 vaccine video series that delivers important information and updates, three times a month. It includes the latest information about DoD vaccine distribution, the TRICARE health benefit, and vaccine availability for a DoD-affiliated, and TRICARE beneficiary audience.

Recommended Content:

COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

DHA, HA leaders discuss MHS Transformation at AHA panel

Article
5/6/2021
Military personnel talking at a podium

Army Lt. Gen. (Dr.) Ronald Place and Dr. Terry Adirim discussed MHS Transformation, MHS GENESIS, and highlighted the DHA’s response to COVID-19 in a virtual roundtable hosted April 12 by the American Hospital Association.

Recommended Content:

MHS GENESIS | Military Health System Transformation | Genesis of MHS GENESIS | Coronavirus | Readiness Capabilities

Janssen COVID-19 vaccine returns to Military Health System

Article
5/4/2021
Military personnel wearing a face mask and a face shield administering the COVID-19 vaccine

Doses of the Janssen COVID-19 vaccine became available April 29 to those in the Military Health System eligible and authorized to receive COVID-19 vaccinations.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

U.S. continues sending medical supplies to India for COVID-19 fight

Article
5/3/2021
A picture of a C-5M Super Galaxy

DOD provides medical aid to India in the fight against the COVID-19 global pandemic.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Easy as 1-2-3 Screensaver

Infographic
5/3/2021
Graphic saying that beneficiaries can scan the QR code or visit www.TRICARE.mil/VaccineAppointments to see what appointment tool their DOD vaccine site is using. Graphic is framed by navy boarders and includes a QR code, and the TRICARE logo on the bottom center.

Graphic saying that beneficiaries can scan the QR code or visit www.TRICARE.mil/VaccineAppointments to see what appointment tool their DOD vaccine site is using. Graphic is framed by navy boarders and includes a QR code, and the TRICARE logo on the bottom center.

Recommended Content:

COVID-19 Vaccine Toolkit | Vaccine Eligibility

Easy as 1-2-3 Graphic

Infographic
5/3/2021
Graphic stating scheduling their COVID-19 vaccine appointment is easy and links to www.TRICARE.mil/VaccineAppointments. Graphic is framed by navy boarders and includes a scannable QR code, and the TRICARE and MHS logo on the bottom center.

Graphic stating scheduling their COVID-19 vaccine appointment is easy and links to www.TRICARE.mil/VaccineAppointments. Graphic is framed by navy boarders and includes a scannable QR code, and the TRICARE and MHS logo on the bottom center.

Recommended Content:

COVID-19 Vaccine Toolkit | Vaccine Eligibility

U.S. Army Medical Team Administers COVID-19 Vaccines in Guam

Article
4/29/2021
Military health personnel wearing a face mask administering the COVID-19 vaccine

Army medical professionals assist in administering COVID-19 vaccine doses to local Guamanians.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts | Readiness Capabilities

Military kids are resilient, but far from immune to pandemic effects

Article
4/28/2021
Military personnel wearing face mask holding up posters for Month of the Military Child

Military children are known for being resilient to constant change, but COVID-19 has affected their mental health, too.

Recommended Content:

Month of the Military Child Toolkit | Children's Health | COVID-19 Vaccine Toolkit | Staying Resilient | Coronavirus

COVID-19 remote patient monitoring pilot marks initial successes

Article
4/27/2021
Photo of Army Maj. Daniel Yourk

Virtual health and other digital health technologies are an essential part of care delivery going forward for all patients, and especially the most vulnerable.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Join Us!! Fourth COVID-19 Townhall Update with Lt. Col. Matthew T. Swingholm!

Article
4/27/2021
Fourth MHS Town Hall announcement with image of Lt. Col. Matthew T. Swingholm, discussing the Critical Need for Blood Donations, Wednesday, April 28 at 2 p.m. ET

Join us for the MHS' Fourth COVID-19 Townhall Update with Lt. Col. Matthew T. Swingholm

Recommended Content:

Armed Services Blood Program | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

DHA’s immunization health care specialists support vaccine rollout

Article
4/26/2021
Military personnel getting COVID-19 vaccines ready

The Defense Health Agency’s Immunization Health Care Division specialists were instrumental in rolling out the COVID-19 vaccines to Department of Defense military medical treatment facilities around the world.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit
<< < 1 2 3 4 5  ... > >> 
Showing results 46 - 60 Page 4 of 35

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.